Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal InsulinThomas W. Martens, Amy Change, Georgia M. Davis et al.|JAMA|2021Cited by 491
Coordinated Care to Optimize Cardiovascular Preventive Therapies in Type 2 DiabetesNeha J. Pagidipati, Jairo Cruz, Adam J. Nelson et al.|JAMA|2023Cited by 93
Incorporating SGLT2i and GLP-1RA for Cardiovascular and Kidney Disease Risk Reduction: Call for Action to the Cardiology CommunityAdam J. Nelson, Christopher B. Granger, Neha J. Pagidipati et al.|Circulation|2021Cited by 79
Use of Lipid-, Blood Pressure–, and Glucose-Lowering Pharmacotherapy in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular DiseaseAdam J. Nelson, Christopher B. Granger, Emily C. O’Brien et al.|JAMA Network Open|2022Cited by 73
Impact of a Pilot Structured Mobile Technology Based Lifestyle Intervention for Patients with Nonalcoholic Fatty Liver DiseaseMonica A. Tincopa, Anna S. Lok, Angela J. Woodiwiss et al.|Digestive Diseases and Sciences|2021Cited by 33